Meeting the human
Journal Title: OncoReview - Year 2013, Vol 3, Issue 1
Abstract
We often have to deal with problems which force us to making difficult choices and decisions that have not only clinical aspects but also ethical during the oncologist’s work. Unfortunately there is not enough place in available medical literature given for dilemmas which oncologists meet in their work. We would like to encourage you to share your doubts and present descriptions of situations which were difficult for you in the pages of our newspaper. By example of a patient who got treatment in our hospital we present dilemmas which appeared in our mutual contacts and became an inspiration to further thoughts. We also discuss such issues as doctor’s attitude to dying patient, the problem of restricting medical procedures and patient–doctor relation.
Authors and Affiliations
Anna Walaszkowska-Czyż, Małgorzata Kuc-Rajca
Keywords
Related Articles
- EP ID EP53194
- DOI -
- Views 220
- Downloads 0
Effective treatment of severe hypertensive crisis in 2-year-old child with neuroblastoma
We describe a case of a 2-year-old boy with neuroblastoma and high catecholamine levels which developed a severe hypertensive crisis. An oral propranolol and oral angiotensin-converting enzyme inhibitor were used with a...
Long-standing acromegaly in a patient with a pituitary adenoma not visible on MRI
Introduction: Acromegaly in the course of a pituitary microadenoma or neuroendocrine GHRH-secreting tumour (GHRH, growth hormone-releasing hormone) invisible on MRI is very rare. Objective: To present the difficulties in...
A role of JAK in the pathogenesis of Philadelphia negative myeloproliferative neoplasms. Target therapy possibilities
In recent years a significant progress has been made in understanding of the pathogenesis of myeloproliferative neoplasms, especially the one with mutation in JAK2 gene. In 2005 several study groups confirmed the presenc...
The cardiac safety during treatment with sunitinib and sorafenib, multikinase angiogenesis inhibitors
Cardiotoxicity of multikinase angiogenesis inhibitors, sunitinib and sorafenib, is most often myocardial systolic dysfunction or arterial and venous thromboembolic events. Essential risk factor seems to be iatrogenic art...
The effect of lipegfilgrastim on hematopoietic reconstitution and supportive treatment after megachemotherapy with autologous peripheral blood stem cell transplantation in patients with lymphoproliferative malignancies
Megachemotherapy with autologous peripheral blood stem cell transplantation (auto-PBSCT) is a standard treatment option in patients below 70 years of age with multiple myeloma (MM) as well as with relapsed and refractory...